View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Endocrinology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 13, 2024
1 min read
Save

Glucagon-like peptide-1 receptor agonists may benefit patients without diabetes after TKA

Glucagon-like peptide-1 receptor agonists may benefit patients without diabetes after TKA

DALLAS — Glucagon-like peptide-1 receptor agonists may reduce complications after total knee arthroplasty in patients with obesity but who are not diabetic, according to presented results.

SPONSORED CONTENT
November 13, 2024
6 min read
Save

Q&A: Intuitive eating can help people with diabetes improve their relationship with food

Q&A: Intuitive eating can help people with diabetes improve their relationship with food

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Bonnie R. Giller, MS, RDN, CDN, CDCES, registered dietitian nutritionist and certified intuitive eating counselor, about the concept of intuitive eating and how patients with diabetes can embrace this approach to help manage their blood sugar levels.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
November 13, 2024
2 min read
Save

Glucagon-like peptide-1 receptor agonists may need to be halted 2 weeks prior to TJA

Glucagon-like peptide-1 receptor agonists may need to be halted 2 weeks prior to TJA

DALLAS — Results presented at the American Association of Hip and Knee Surgeons Annual Meeting showed 14 days may be the optimal cutoff time for glucagon-like peptide-1 receptor agonists prior to primary hip or knee arthroplasty.

SPONSORED CONTENT
November 13, 2024
1 min read
Save

Older age at natural menopause may increase asthma risk

Older age at natural menopause may increase asthma risk

Later age at natural menopause may be a risk factor for asthma, potentially due to prolonged estrogen exposure, data from a longitudinal study show.

SPONSORED CONTENT
November 13, 2024
2 min read
Save

Low-income, minority community redevelopment may reduce obesity disparities

Low-income, minority community redevelopment may reduce obesity disparities

SAN ANTONIO — Redevelopment of low-income minority communities may help to reduce obesity disparities in this patient population, according to findings presented at ObesityWeek.

SPONSORED CONTENT
November 13, 2024
4 min watch
Save

VIDEO: ‘What you can do now’ for patients with MASLD

VIDEO: ‘What you can do now’ for patients with MASLD

PHILADELPHIA — In this video, Nancy S. Reau, MD, FAASLD, AGAF, provides an overview of her postgraduate course presentation at the ACG Annual Scientific Meeting.

SPONSORED CONTENT
November 12, 2024
2 min read
Save

Income may factor into mortality risk among adults with type 2 diabetes

Income may factor into mortality risk among adults with type 2 diabetes

Low income corresponded with a higher risk for death among individuals with type 2 diabetes, a South Korean-based cohort analysis published in JAMA Network Open suggested.

SPONSORED CONTENT
November 12, 2024
2 min read
Save

Income, insurance status contributes to rationing prescription drugs due to cost

Income, insurance status contributes to rationing prescription drugs due to cost

SAN ANTONIO — Due to structural barriers such as low income and inadequate insurance coverage, Black and Hispanic adults were more likely to ration prescription drugs to save money, researchers reported.

SPONSORED CONTENT
November 11, 2024
2 min read
Save

High- vs. moderate-intensity exercise reduces ghrelin levels regardless of sex

High- vs. moderate-intensity exercise reduces ghrelin levels regardless of sex

Regardless of sex, high- vs. moderate-intensive exercise may better reduce ghrelin levels, but its effect on hunger perceptions may differ between men and women, according to results published in the Journal of the Endocrine Society.

SPONSORED CONTENT
November 11, 2024
3 min read
Save

Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables

Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables

SAN ANTONIO — Once-daily oral semaglutide conferred more weight loss vs. placebo plus lifestyle intervention and was similar vs. larger oral GLP-1 receptor agonist doses and weekly injectables for efficacy and safety, a speaker reported.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails